Skip to Main Content

Author Details

Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
1980
556
79
PMIDPaper TitleJournal TitlePublished Year
33109413Corrigendum to "Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy" [Canc. Lett 244 (2006) 182-189].Cancer Lett2021
29963769Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro.Cancer Med2018
35540547Generation of an oxoglutarate dehydrogenase knockout rat model and the effect of a high-fat diet.RSC Adv2018
27911865Mitochondrial pyruvate carrier function is negatively linked to Warburg phenotype in vitro and malignant features in esophageal squamous cell carcinomas.Oncotarget2017
28240424Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study.Prostate2017
28179591Correction: MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features.Oncotarget2017
28624784Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells.Oncotarget2017
28698547Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells.Sci Rep2017
28585395Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors.APMIS2017
28789597MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells.Tumour Biol2017
28076853Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers.Oncotarget2017
26722063Aldehyde Dehydrogenase-1 Expression Predicts Unfavorable Outcomes in Patients with Esophageal Squamous Cell Carcinoma.Anticancer Res2016
26477789The relationship between perineural invasion, tumor grade, reactive stroma and prostate cancer-specific mortality: A clinicopathologic study on a population-based cohort.Prostate2016
27852261MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer.BMC Cancer2016
27725913Prognostic and clinicopathological significance of Cacna2d1 expression in epithelial ovarian cancers: a retrospective study.Am J Cancer Res2016
27725912Decreased expression of pyruvate dehydrogenase A1 predicts an unfavorable prognosis in ovarian carcinoma.Am J Cancer Res2016
27835892Establishment of mitochondrial pyruvate carrier 1 (MPC1) gene knockout mice with preliminary gene function analyses.Oncotarget2016
27273130Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.Cancer Med2016
27271973Combining lymphovascular invasion with reactive stromal grade predicts prostate cancer mortality.Prostate2016
27556703Generation of TALEN-mediated FH knockout rat model.Oncotarget2016
27220319Expression and clinical significance of Wee1 in colorectal cancer.Tumour Biol2016
27462778PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence.Oncotarget2016
27248169MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features.Oncotarget2016
26771843Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors.Oncotarget2016
26870350Expression of zinc finger E-box-binding homeobox factor 1 in epithelial ovarian cancer: A clinicopathological analysis of 238 patients.Mol Clin Oncol2016
25224722High nuclear SOX2 expression is associated with radiotherapy response in small (T1/T2) oral squamous cell carcinoma.J Oral Pathol Med2015
26547370Nuclear, cytoplasmic, and stromal expression of ZEB1 in squamous and small cell carcinoma of the esophagus.APMIS2015
26413751Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells in vitro.Oncotarget2015
26408721Decreased Expression of PDHE1α Predicts Worse Clinical Outcome in Esophageal Squamous Cell Carcinoma.Anticancer Res2015
26504037Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.Anticancer Res2015
26528857ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro.Oncotarget2015
26124324PDGFR-α and CD117 Expression Pattern in Esophageal Carcinomas.Anticancer Res2015
26124317Mitochondrial DNA Deficiency in Ovarian Cancer Cells and Cancer Stem Cell-like Properties.Anticancer Res2015
26148881The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study.BMC Cancer2015
25849598Expression of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (total) and pCyclin B1(Ser126) in vulvar squamous cell carcinoma and their relations with clinicopatological features and prognosis.PLoS One2015
25620661The prognostic value of reactive stroma on prostate needle biopsy: a population-based study.Prostate2015
25466510High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targeting.Eur J Cancer2015
25428750Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience.Scand J Urol2015
25455994The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.Hum Pathol2015
24577056Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.Br J Cancer2014
25380303CD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients.PLoS One2014
25170745The length of a positive surgical margin is of prognostic significance in patients with clinically localized prostate cancer treated with radical prostatectomy.Urol Int2014
25139714B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome.BMC Cancer2014
24915603Modification of extracorporeal photopheresis technology with porphyrin precursors. Comparison between 8-methoxypsoralen and hexaminolevulinate in killing human T-cell lymphoma cell lines in vitro.Biochim Biophys Acta2014
24904831Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series.Front Oncol2014
24511023Aldehyde dehydrogenase-1 predicts favorable prognosis in patients with vulvar squamous cell carcinoma.Anticancer Res2014
22632270Disseminated tumour cells in bone marrow of patients with uveal melanoma.Acta Ophthalmol2013
24386165Sex hormone-binding globulin (SHBG) expression in ovarian carcinomas and its clinicopathological associations.PLoS One2013
24092823Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide.J Clin Endocrinol Metab2013
24035332Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer.Int J Radiat Oncol Biol Phys2013
  • 1 - 50 of 556

Recommended Authors

Institut Curie
Career Start Year 1999
Number of shared co-authors 0
Health Research Institute Hospital La Fe
Career Start Year 1999
Number of shared co-authors 0
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
University of Southern California
Career Start Year 1995
Number of shared co-authors 0
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 3
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 4
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 5
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 2
University of British Columbia
Career Start Year 1987
Number of shared co-authors 4
Queen Elizabeth University Hospital
Career Start Year 1986
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 1
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
University of Kansas
Career Start Year 1985
Number of shared co-authors 0
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1984
Number of shared co-authors 2
Chugai Pharmaceutical Co. Ltd.
Career Start Year 1984
Number of shared co-authors 0
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 6
University of Oxford
Career Start Year 1981
Number of shared co-authors 5
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 5
MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 3
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 0
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 1978
Number of shared co-authors 5
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 0
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
Oita University
Career Start Year 1965
Number of shared co-authors 0
Sao Paulo University
Career Start Year 1964
Number of shared co-authors 0

Collaborators

Institute for Cancer Research, Oslo University Hospital
Co-authored papers 46
Second Affiliated Hospital of Nanchang University
Co-authored papers 36
Oslo University Hospital
Co-authored papers 14
Oslo University Hospital
Co-authored papers 8
Oslo University Hospital
Co-authored papers 6
Institute for Cancer Research, Oslo University Hospital - Radium Hospital
Co-authored papers 5
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 4
Karolinska Institute
Co-authored papers 4
Memorial Sloan-Kettering Cancer Center
Co-authored papers 3
Institute for Cancer Research, The Norwegian Radium Hospital
Co-authored papers 3
Center for Bioinformatics, University of Oslo
Co-authored papers 3
Centro Hospitalar Universitario de Sao Joao.
Co-authored papers 2
Cancer Science Institute of Singapore, National University of Singapore
Co-authored papers 2
Bluestar Genomics Inc.
Co-authored papers 2
UQ Centre for Clinical Research, The University of Queensland
Co-authored papers 2
Co-authored papers 2
Cancer Registry of Norway
Co-authored papers 2
Seattle Children's Hospital, University of Washington
Co-authored papers 2
Radiumhospitalet, Oslo University Hosptial
Co-authored papers 2
University of Queensland
Co-authored papers 2
National Taiwan University College of Medicine
Co-authored papers 2
Queen's University Belfast
Co-authored papers 1
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 1
Westmead Hospital
Co-authored papers 1
Calico Life Sciences LLC
Co-authored papers 1
The University of Glasgow
Co-authored papers 1
The Eye Cancer Clinic, Princess Margaret Cancer Centre, Hospital for Sick Children
Co-authored papers 1
Co-authored papers 1
Central Finland Hospital Nova
Co-authored papers 1
University of Leeds
Co-authored papers 1